Xuhui District Center for Disease Control and Prevention, Shanghai, 200237, China.
Shanghai Institute of Medical Imaging, Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
J Nanobiotechnology. 2020 Aug 3;18(1):108. doi: 10.1186/s12951-020-00668-5.
Drug delivery systems (DDSs) based on nanomaterials have shown a promise for cancer chemotherapy; however, it remains a great challenge to localize on-demand release of anticancer drugs in tumor tissues to improve therapeutic effects and minimize the side effects. In this regard, photoresponsive DDSs that employ light as an external stimulus can offer a precise spatiotemporal control of drug release at desired sites of interest. Most photoresponsive DDSs are only responsive to ultraviolet-visible light that shows phototoxicity and/or shallow tissue penetration depth, and thereby their applications are greatly restricted. To address these issues, near-infrared (NIR) photoresponsive DDSs have been developed. In this review, the development of NIR photoresponsive DDSs in last several years for cancer photo-chemotherapy are summarized. They can achieve on-demand release of drugs into tumors of living animals through photothermal, photodynamic, and photoconversion mechanisms, affording obviously amplified therapeutic effects in synergy with phototherapy. Finally, the existing challenges and further perspectives on the development of NIR photoresponsive DDSs and their clinical translation are discussed.
基于纳米材料的药物传递系统(DDS)在癌症化疗中显示出了巨大的应用潜力;然而,如何实现抗癌药物在肿瘤组织中的按需定位释放,以提高治疗效果并最小化副作用,仍然是一个巨大的挑战。在这方面,光响应 DDS 可以利用光作为外部刺激,在所需的感兴趣部位提供药物释放的精确时空控制。大多数光响应 DDS 仅对具有光毒性和/或浅层组织穿透深度的紫外可见光有响应,因此其应用受到极大限制。为了解决这些问题,人们开发了近红外(NIR)光响应 DDS。本文总结了近年来用于癌症光化疗的 NIR 光响应 DDS 的发展。它们可以通过光热、光动力和光转换机制将药物按需递送到活体动物的肿瘤中,与光疗协同作用,显著增强治疗效果。最后,讨论了 NIR 光响应 DDS 的发展及其临床转化所面临的现有挑战和进一步展望。